Synapse - Works

Results (117469)

Age-adjusted co-morbidity core - but not revised Disease Risk Index - is associated with progression-free survival after intermediate intensity double unit CBT in adults with hematologic malignancies

Meeting Abstract

Kosuri, S.; Hilden, P.; Devlin, S.; Yoo, Y.; Lauer, E.; Peled, J.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Castro-Malaspina, H.; more...
Blood (2015)

Fulltext@MSK | Save

Platelet function disorders in bleeding patients without other coagulopathies

Meeting Abstract

Dembitzer, F. R.; Peerschke, E. I. B.; Cromwell, C.; Zhang, X. F.; Aledort, L. M.
Blood (2015)

Fulltext@MSK | Save

Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma

Meeting Abstract

Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S.
Blood (2015)

Fulltext@MSK | Save

Cytogenetics in hairy cell leukemia at diagnosis and relapse: The rate of therapy-related myeloid malignancies is low

Meeting Abstract

Getta, B.; Abdel-Wahab, O.; Park, J. H.; Tallman, M. S.
Blood (2015)

Fulltext@MSK | Save

Targeted sequencing reveals a relationship between mutational burden and clinical phenotype in MPNs

Meeting Abstract

Getta, B.; Rapaport, F.; Devlin, S.; Zhao, C.; Knapp, K. M.; Patel, M.; Mohanty, A.; Van den Brink, M.; Levine, R. L.; Arcila, M.; more...
Blood (2015)

Fulltext@MSK | Save

An HSP90 inhibitor, PU-H71, antagonizes stroma-induced pro-survival effects in CLL through its inhibition of multi-component B-cell receptor signaling pathway

Meeting Abstract

Guo, A. L.; Lu, P.; Zhen, C.; Chiosis, G.; Wang, Y. L.
Blood (2015)

Fulltext@MSK | Save

Phase 1/1b study of the novel immunotoxin MT-3724 in relapsed/refractory non-Hodgkin's B-cell lymphoma (NHL)

Meeting Abstract

Hamlin, P. A.; Diefenbach, C. S.; Valacer, D. J.; Higgins, J.; Fanale, M. A.
Blood (2015)

Fulltext@MSK | Save

Clinical and correlative results of a phase 1 study of cerdulatinib (PRT062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies

Meeting Abstract

Hamlin, P. A.; Flinn, I.; Wagner-Johnston, N.; Burger, J. A.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G. P.; Leeds, J. M.; Curnutte, J. T.; more...
Blood (2015)

Fulltext@MSK | Save

Adoptively transferred CMV-specific T-cells responsive to immunodominant CMVpp65 epitopes extend durable in-vivo suppression of clonogenic CMVpp65 [+] human colon carcinoma cells in comparison to T-cells responsive to subdominant epitopes

Meeting Abstract

Hasan, A. N.; Selvakumar, A.; Kuo, T. Y.; O'Reilly, R. J.
Blood (2015)

Fulltext@MSK | Save

The RIG-I agonist 3pRNA synergizes with checkpoint blockade in cancer immunotherapy

Meeting Abstract

Heidegger, S.; Kreppel, D.; Bscheider, M.; Wintges, A.; Bek, S.; Schmickl, M.; Ruland, J.; Peschel, C.; van den Brink, M.; Haas, T.; more...
Blood (2015)

Fulltext@MSK | Save